Nicholas Investment Partners, LP Alx Oncology Holdings Inc Transaction History

Nicholas Investment Partners, LP

  • $912 Million
  • Q4 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022
SELL
$21.49 - $74.4 $1.03 Million - $3.56 Million
-47,872 Closed
0 $0
Q3 2021

Nov 15, 2021
SELL
$52.51 - $80.91 $625,814 - $964,285
-11,918 Reduced 19.93%
47,872 $3.54 Million
Q2 2021

Aug 10, 2021
BUY
$52.2 - $75.23 $838,227 - $1.21 Million
16,058 Added 36.72%
59,790 $3.27 Million
Q1 2021

May 14, 2021
SELL
$62.84 - $87.68 $18,852 - $26,304
-300 Reduced 0.68%
43,732 $3.23 Million
Q4 2020

Feb 11, 2021
BUY
$34.11 - $112.26 $1.5 Million - $4.94 Million
44,032 New
44,032 $3.8 Million

Others Institutions Holding ALXO

# of Institutions
96
Shares Held
39.5M
Call Options Held
213K
Put Options Held
44.8K
View Full List

About ALX ONCOLOGY HOLDINGS INC

ALXO Quotes by TradingView
  • Ticker ALXO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,747,100
  • Market Cap $43.2M
  • Description
  • ALX Oncology Holdings Inc., a clinical-stage immuno-oncology company, focuses on developing therapies for patients fighting cancer. Its lead product candidate is ALX148, a CD47 blocking therapeutic that is in Phase 1b/2 clinical trial used for the treatment of myelodysplastic syndromes; and for the treatment of acute myeloid leukemia and non-Hod...
More about ALXO
Track This Portfolio

Track Nicholas Investment Partners, LP Portfolio

Follow Nicholas Investment Partners, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nicholas Investment Partners, LP, based on Form 13F filings with the SEC.

News

Stay updated on Nicholas Investment Partners, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email